Neuren Pharmaceuticals | NEU - Net Income

Stock Price
13.44
Daily Change
0.73 5.74%
Monthly
-22.89%
Yearly
-5.35%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD7.52M in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Akebia Therapeutics USD 6.11M 28.92M Mar/2025
Alaunos Therapeutics USD -1.16M 417K Sep/2025
Avita Medical AUD -9.92M 1.67M Jun/2025
Clinuvel Pharmaceuticals AUD 24.7M 13.76M Jun/2024
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Genetic Signatures AUD -15.2M 7.81M Dec/2024
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
Medical Developments International AUD -105K 409K Jun/2025
Neuren Pharmaceuticals AUD 7.52M 126.51M Jun/2025
Organon & Co USD 160M 15M Sep/2025
Paradigm Biopharmaceuticals AUD -6.42M 495.95K Jun/2025
PYC Therapeutics AUD -12.37M 13.2M Jun/2025
Starpharma Holdings AUD -2.3M 3.09M Jun/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Telix Pharmaceuticals AUD -4.83M 2.54M Dec/2025
Viatris USD -340.1M 211.9M Dec/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025